States restrict Medicaid coverage for GLP-1 weight-loss drugs amid rising costs
Several states have ended Medicaid coverage for GLP-1 drugs, citing unsustainable costs despite rising obesity rates.
2 min read
live feed
#wire#us+3 more
Several states have ended Medicaid coverage for GLP-1 drugs, citing unsustainable costs despite rising obesity rates.
The proposed 2027 budget cuts health department funding by 12% while increasing military spending by 42%.